Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-30 @ 12:12 AM
Study NCT ID:
NCT01644968
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2012-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Sponsor:
Providence Health & Services
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
03-066A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None